Non-Small Cell Lung Cancer Coverage from Every Angle
Editor:
David S. Ettinger, MD
Advertisement
Advertisement

David J. Kwiatkowski, MD, PhD, on Clinical Implications of Neoadjuvant Atezolizumab for Resectable Non–Small Cell Lung Cancer

Justin F. Gainor, MD, on Non–Small Cell Lung Cancer: Treatment Update on BLU-667
Suresh S. Ramalingam, MD, on Managing Pyrexia With Dabrafenib/Trametinib in Advanced NSCLC
Recent
News

EMERGING-CTONG 1103 Trial: Neoadjuvant Erlotinib in EGFR-Mutant Lung Cancer

Entrectinib Approved by FDA for ROS1-Positive NSCLC

Two-Drug Combination Targets Resistance in Cancer

Early Results With Dual Inhibition of VEGFR2 and PD-1 in Advanced Lung Cancer

View More >
Published
Medical Literature

IMpower130 Supports Atezolizumab Inclusion in Stage IV Lung Cancer Therapy

Is Biennial Lung Cancer Screening Safe and Effective?

How an Intervention Trial Addressed Racial Disparities in Treatment of Early-Stage Cancers

Does Stereotactic Body Radiotherapy Enhance the Effect of Immunotherapy for Lung Cancer?

View More >
Ongoing
CE Activities

Proceedings from the 15th Annual Winter Lung Cancer Conference

Advanced Non-Small Cell Lung Ccancer Patient Management Simulator

An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC

Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care-Lung Cancer: Advanced Disease

View More >
Available
Clinical Trials

Fred and Pamela Buffett Cancer Center

Fred Hutchinson Cancer Research Center / Seattle Cancer Care Alliance

University of Colorado Cancer Center

City of Hope Comprehensive Cancer Center

View More >
Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.